(Q77365555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

J Derelle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E Bertolo-Houriez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Marchal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Weber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Vidailhet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Archives de Pediatrie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

371-377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

Identification of the cystic fibrosis gene: chromosome walking and jumping

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

rhDNase: scientific background, cloning and production

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Liquefaction of viscous purulent exudates by deoxyribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

The Management of Cystic Fibrosis with Carbocysteine Lysine Salt: Single-Blind Comparative Study with Ambroxol Hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

DNase trials in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase

1 reference

https://api.crossref.org/works/10.1016%2FS0929-693X%2898%2980022-5

7 January 2021

10.1016/S0929-693X(98)80022-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759155%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference